These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 10469746)

  • 41. [Ovarian neoplasms. Protective or hazardous effects of sterilization, hysterectomy and hormonal infertility therapy?].
    Persson I; Janson PO
    Lakartidningen; 1995 Feb; 92(5):371-4. PubMed ID: 7853904
    [No Abstract]   [Full Text] [Related]  

  • 42. Ovarian cancer and talc: a case-control study.
    Cramer DW; Welch WR; Scully RE; Wojciechowski CA
    Cancer; 1982 Jul; 50(2):372-6. PubMed ID: 7083145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is tubal sterilization associated with an increased risk of subsequent hysterectomy but a decreased risk of ovarian cancer? A review of recent literature.
    Chi IC
    Adv Contracept; 1996 Jun; 12(2):77-99. PubMed ID: 8863904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perineal talc use and ovarian cancer risk: a case study of scientific standards in environmental epidemiology.
    Huncharek M; Muscat J
    Eur J Cancer Prev; 2011 Nov; 20(6):501-7. PubMed ID: 21712717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Events of reproductive life and the incidence of epithelial ovarian cancer.
    Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
    Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.
    Piek JM; Kenemans P; Verheijen RH
    Am J Obstet Gynecol; 2004 Sep; 191(3):718-32. PubMed ID: 15467531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
    Hanley GE; McAlpine JN; Pearce CL; Miller D
    Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Endometriosis and endometriosis-related ovarian neoplasms].
    Totev T; Tomov S; Gorchev G
    Akush Ginekol (Sofiia); 2013; 52(6):38-42. PubMed ID: 24501879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tubal ligation and the risk of ovarian carcinoma.
    Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
    Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study.
    Hankinson SE; Hunter DJ; Colditz GA; Willett WC; Stampfer MJ; Rosner B; Hennekens CH; Speizer FE
    JAMA; 1993 Dec; 270(23):2813-8. PubMed ID: 8133619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pelvic inflammation and the pathogenesis of ovarian cancer: a cohort study.
    McAlpine JN; Lisonkova S; Joseph KS; McComb PF
    Int J Gynecol Cancer; 2014 Oct; 24(8):1406-13. PubMed ID: 25191876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ovarian endometriosis].
    Karseladze AI
    Arkh Patol; 1990; 52(9):24-9. PubMed ID: 2270976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis.
    Cramer DW; Welch WR
    J Natl Cancer Inst; 1983 Oct; 71(4):717-21. PubMed ID: 6578367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
    Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
    Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
    Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesis.
    Emori MM; Drapkin R
    Reprod Biol Endocrinol; 2014 Jul; 12():60. PubMed ID: 24997727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there a link between talcum powder, oxidative stress, and ovarian cancer risk?
    Saed GM
    Expert Rev Anticancer Ther; 2024 Jul; 24(7):485-491. PubMed ID: 38712572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis.
    Massuger L; Roelofsen T; Ham Mv; Bulten J
    Med Hypotheses; 2010 May; 74(5):859-61. PubMed ID: 20022435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
    Schildkraut JM; Bastos E; Berchuck A
    J Natl Cancer Inst; 1997 Jul; 89(13):932-8. PubMed ID: 9214672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.